Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Protagonist Therapeutics (PTGX) Q3 2026 Earnings
PTGX
5
Aug
Confirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.63
0.35
1.32
2.29
Details
Expected EPS
2.266298
Actual EPS
2.29
Surprise EPS
0.02
Surprise Percent
+1.05%
Description
Protagonist Therapeutics (PTGX) has reported earnings of 2.29 per share for Q3 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login